• Rifampin in Research: Applied Workflows & Troubleshooting Ti

  2026-04-30

  Rifampin, a potent rifamycin antibiotic, enables reproducible transcriptional inhibition for advanced studies in bacterial resistance, transcriptional regulation, and synthetic biology. This article details optimized experimental workflows, data-driven troubleshooting, and actionable protocol enhancements using APExBIO’s Rifampin.

• Bifendate Reduces Hepatic Lipids in Mouse Hypercholesterolem

  2026-04-30

  This study demonstrates that Bifendate (DDB), a synthetic derivative of Schisandrin C, selectively decreases hepatic triglyceride and total cholesterol levels in mouse models of diet-induced hypercholesterolemia. The findings clarify Bifendate's role as a hepatoprotective agent targeting hepatic lipid accumulation, with mechanistic implications for preclinical fatty liver research.

• Optimizing Immunofluorescence: HyperFluor™ 594 Goat Anti-Rab

  2026-04-29

  Explore how the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody elevates sensitivity and reproducibility in atherosclerosis immunofluorescence. This article offers original insights on practical assay optimization, protocol nuances, and data interpretation, drawing from recent molecular discoveries.

• Triacetin Digestion and Hepatic Energy Regulation in Rats

  2026-04-29

  This study elucidates the digestive fate of the short-chain triacylglycerol triacetin, demonstrating its complete upper GI tract degradation and rapid absorption as acetic acid and glycerol. The work highlights triacetin’s dual role as both a metabolic substrate and hepatic signaling molecule, with implications for metabolic health interventions.

• β-Sitosterol Targets TBX20 to Suppress Colorectal Cancer Pro

  2026-04-28

  This study identifies β-sitosterol from Herba Sarcandrae as a potent anti-tumor agent in colorectal cancer, acting through upregulation and stabilization of the tumor suppressor TBX20. The findings highlight a network pharmacology approach to uncover bioactive natural product mechanisms and suggest implications for apoptosis and chemosensitization in cancer research.

• Dihydroethidium (DHE): Precision Redox Sensing for Translati

  2026-04-28

  This thought-leadership article explores the mechanistic utility of Dihydroethidium (DHE, hydroethidine) as a next-generation superoxide probe, bridging evidence-based bench protocols with strategic guidance for translational researchers. Integrating recent advances in osteoporosis, apoptosis, and mitochondrial signaling—including insights from the SZQ-3/NF-κB axis—this piece positions APExBIO’s DHE as a linchpin for advancing oxidative stress assays across disease domains, while highlighting practical workflow parameters and future research directions.

• Cy3 TSA Fluorescence System Kit: Ultra-Sensitive Detection i

  2026-04-27

  The Cy3 TSA Fluorescence System Kit enables highly sensitive signal amplification in immunohistochemistry and related assays. Leveraging tyramide signal amplification (TSA) and Cy3 fluorophore chemistry, it permits robust detection of low-abundance targets in fixed tissues. Its validated performance supports advanced research in protein and nucleic acid visualization.

• Ethacridine Lactate Monohydrate in Stem Cell & Chromatin Ass

  2026-04-27

  Ethacridine lactate monohydrate (7-ethoxyacridine-3,9-diamine) sets a new benchmark for microbial control in sensitive cell differentiation and chromatin studies. Its high solubility, purity, and validated antiseptic action make it indispensable for reproducible, contamination-free workflows in cutting-edge research.

• Deferasirox Fe3+ Chelate: Unraveling NF-κB Modulation in Iro

  2026-04-26

  Explore how Deferasirox Fe3+ chelate uniquely modulates NF-κB and mitochondrial ROS to advance iron overload treatment research. This in-depth analysis clarifies its mechanistic impact, research protocols, and translational relevance for hematology scientists.

• Eicosapentaenoic Acid (EPA): Mechanistic Insights for Cardio

  2026-04-25

  Explore the unique cellular and molecular mechanisms of Eicosapentaenoic Acid (EPA), a leading omega-3 fatty acid in cardiovascular and immune research. This article delivers in-depth analysis, protocol guidance, and practical insights beyond standard workflows.

• Caspase-3 Cleavage of NDUFS1 Drives Trichothecene-Induced Mi

  2026-04-24

  This study uncovers the central role of caspase-3-mediated cleavage of mitochondrial NDUFS1 in trichothecene-induced ROS accumulation and liver toxicity, integrating insights from both mitochondrial and ER oxidative pathways. The findings clarify mechanistic links between mitochondrial dysfunction, ROS amplification, and hepatotoxicity, with implications for future research on oxidative stress and therapeutic intervention.

• Gemcitabine in Precision Cancer Research: Mechanisms, Checkp

  2026-04-24

  Explore the advanced mechanisms of Gemcitabine in cancer research, with a focus on DNA synthesis inhibition, checkpoint activation, and assay design. This article uniquely bridges molecular pathways and experimental strategy, offering a distinct perspective for oncological studies.

• Cdk5 Downregulation Mitigates Neuronal Ferroptosis Post-Stro

  2026-04-23

  This study demonstrates that downregulating Cdk5 reverses ferroptosis in hippocampal neurons after ischemic stroke by modulating the AMPK pathway and microglial polarization. The findings provide mechanistic insights for neuroprotection and highlight methodological approaches for live-cell intracellular iron detection.

• CDC42 Controls HBV Entry via NTCP Trafficking and Macropinoc

  2026-04-23

  This study demonstrates that CDC42 activity is essential for efficient hepatitis B virus (HBV) entry into hepatocytes, operating through both recycling endosome-dependent NTCP translocation and macropinocytosis. The findings provide mechanistic insight into viral entry pathways and highlight new antiviral targets in Rho GTPase signaling.

• Hyperthermia and Cisplatin Synergize via Caspase-8–Mediated

  2026-04-22

  This study uncovers how combining hyperthermia with cisplatin therapy promotes caspase-8 accumulation and activation, leading to enhanced apoptosis and pyroptosis in cancer cells. The findings clarify the molecular mechanisms underlying this synergy, providing a rationale for targeting caspase-8 in combination therapies for cancer.

16209 records 1/1081 page Next 12345 下5页 Last page